ClinicalTrials.gg
Sign In

BlueRock Therapeutics clinical trials

Acquired by Bayer, Sep 20, 2019 · source ↗

The registry lists 5 studies whose lead sponsor is BlueRock Therapeutics. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 2, 2026.

Before and after it joined Bayer

First submitted before BlueRock Therapeutics became part of Bayer
0
First submitted after BlueRock Therapeutics became part of Bayer
5
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Coming up

1 of BlueRock Therapeutics’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

All 5 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now360%Recruiting 2 · Enrolling by invitation 1
  • Under way, not recruiting120%
  • Completed120%

Phase

  • Phase 12
  • Phase 31
  • Phase 21

Where

  • United States5
  • Canada4
  • Spain1
  • Australia1
  • Italy1
  • Germany1

Over the years

  1. 21
  2. 22
  3. 23
  4. 24
  5. 225
  6. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • BlueRock Therapeutics5 studies

Something wrong with this grouping? Tell us on the Bayer page.

Studies

Recruiting first, then most recently updated. Showing 5 of 5. All Bayer studies →